MARK MIEDEMA: Open Payments
NPI 1205063211 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,081 in 86 payments from 8 companies in 2025. Trend: 2023 $7,144 · 2024 $2,735 · 2025 $6,081
Consulting: $3,153Food & beverage: $1,816Travel & lodging: $1,093Education: $20
| Company | Payments | Amount |
|---|---|---|
| BIOTISSUE HOLDINGS INC. | 11 | $3,544 |
| Abbott Laboratories | 17 | $1,211 |
| Saluda Medical Americas, Inc. | 30 | $770 |
| Medtronic, Inc. | 21 | $386 |
| Globus Medical, Inc. | 3 | $72 |
| Stryker Corporation | 2 | $60 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Averitas Pharma Inc. | 1 | $18 |
Products named: PROCLAIM, Evoke, INCEPTIV, ETERNA, MILD DEVICE KIT, Senza, SYNCHROMEDII, OCTRODE.
Industry payments across AR — which companies pay providers there.
